$1.24
-0.01 (-0.80%)
Open$1.26
Previous Close$1.25
Day High$1.35
Day Low$1.23
52W High$2.60
52W Low$0.73
Volume—
Avg Volume163.8K
Market Cap148.56M
P/E Ratio—
EPS$-0.11
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,959.7% upside
Current
$1.24
$1.24
Target
$37.94
$37.94
$25.58
$37.94 avg
$45.71
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 60.16M | 53.18M | 50.95M |
| Net Income | -7,561,680 | -6,775,030 | -7,233,045 |
| Profit Margin | -12.6% | -12.7% | -14.2% |
| EBITDA | -8,587,792 | -7,436,735 | -8,070,839 |
| Free Cash Flow | -10,429,515 | -10,842,286 | -7,296,543 |
| Rev Growth | -4.1% | +12.5% | -5.7% |
| Debt/Equity | 1.23 | 1.43 | 1.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |